CTKB vs PACB
Cytek Biosciences, Inc. - Common Stock · Pacific Biosciences of California, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | CTKB | PACB |
|---|---|---|
| Price | $6.13 | $2.61 |
| Market Cap | $796.80M | $809.71M |
| P/E | — | — |
| P/B | 2.47 | — |
| P/S | 3.95 | 5.06 |
| ROE | -20.7% | — |
| Net Margin | -33.0% | -341.5% |
| Gross Margin | 51.8% | 28.6% |
| Revenue Growth | 0.5% | 3.9% |
| Dividend Yield | — | — |
| EPS | -$0.51 | -$1.76 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.